Back to Editor profile » Dr Eileen O'Reilly

Dr Eileen O'Reilly

Dr Eileen O'Reilly

Associate Editor-in-Chief: Eileen M. O'Reilly

Dr. Eileen M. O’Reilly serves as the Section Head for Hepatopancreaticobiliary/ Neuroendocrine Cancers, Gastrointestinal Oncology Service, Associate Director for the David M. Rubenstein Center for Pancreatic Cancer at Memorial Sloan Kettering (MSK) and is an Attending Physician and Member at MSK and Professor of Medicine at Weill Cornell Medical College. Dr. O’Reilly holds the Winthrop Rockefeller Endowed Chair in Medical Oncology.

Dr. O’Reilly received her medical degree at Trinity College (Dublin University) in Ireland. She completed her residency training in Ireland and Fellowship training at MSK. Dr. O’Reilly has pancreatic and hepatobiliary malignancies as the major focus of her research and clinical activities. Research directions include integration of molecular and genetic-based therapies for the treatment of pancreas cancer along with development of adjuvant and neoadjuvant therapies and identification of biomarkers for therapy selection. Dr. O’Reilly teaches and mentors junior faculty, oncology fellows, residents and medical/other students and has numerous teaching and other awards. Dr. O’Reilly is the Principal Investigator of multiple trials in pancreas cancer and has authored/co-authored > 250 articles, editorials and book chapters.

Dr. O’Reilly’s other responsibilities include: Chair of MSK’s Institutional Review & Privacy Board (IRB-B), Chair of the Data and Safety Monitoring Committee (DSMC) and Chair of the Continuing Medical Education (CME) committee. Nationally Dr. O’Reilly is Co-Chair of the NCI Alliance Co-Operative Group Gastrointestinal Cancers Committee and serves on the Medical and Scientific Advisory Board of the Pancreatic Cancer Action Network, NCCN Pancreas panel, ASCO Guidelines Committee and the Board of the National Pancreas Foundation.